Home > Market > Market Stats >  Alembic Pharmaceuticals

Company Summary

ALEMBIC PHARMACEUTICALS SUMMARY

Alembic Pharmaceuticals is trading 1.36% lower at Rs 527.95 as compared to its last closing price. Alembic Pharmaceuticals has been trading in the price range of 535.45 & 527.3. Alembic Pharmaceuticals has given -6.59% in this year & -0.64% in the last 5 days.

 

Alembic Pharmaceuticals has TTM P/E ratio 56.31 as compared to the sector P/E of 30.05. There are 18 analysts who have initiated coverage on Alembic Pharmaceuticals. There are 1 analysts who have given it a strong buy rating & 5 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.

 

The company posted a net profit of 121.93 Crores in its last quarter.

 

Listed peers of Alembic Pharmaceuticals include Sanofi India (-1.09%), Glenmark Pharmaceuticals (3.47%), Alembic Pharmaceuticals (-1.36%) etc.

 

Alembic Pharmaceuticals has a 69.61% promoter holding & 30.39% public holding.

FAQs about Alembic Pharmaceuticals

Alembic Pharmaceuticals is trading at 527.95 as on 6 Feb, 2023 3:53:56 PM. This is -1.36% lower as compared to its previous closing price of 535.25
The market capitalization of Alembic Pharmaceuticals is 10519.08 Cr as on 6 Feb, 2023 3:53:56 PM.
The average broker rating on Alembic Pharmaceuticals is Hold. The breakup of analyst rating is given below -
  • 3 analysts have given a strong sell rating
  • 1 analysts have given a sell rating
  • 8 analysts have given a hold rating
  • 5 analysts have given a buy rating
  • 1 analysts have given a strong buy rating
The 52 wk high for Alembic Pharmaceuticals is 792.3 whereas the 52 wk low is 525.3
Alembic Pharmaceuticals can be analyzed on the following key metrics -
  • TTM P/E: 56.31
  • Sector P/E: 30.05
  • Dividend Yield: 1.87%
  • D/E ratio: -
Alembic Pharmaceuticals reported a net profit of 520.93 Cr in 2022.

Recommended For You

Trending Stocks

×
Get alerts on WhatsApp
Set Preferences My ReadsWatchlistFeedbackRedeem a Gift CardLogout